Ongoing Projects

Using DNA methylation from saliva for outcome prediction in oral cancer

Approved 06 July 2023

Identifying Oral Health Needs and Barriers for Head and Neck Cancer Patients in a Large UK Cohort

Approved 25 May 2023

Estimating cancer risk using DNA methylation proxies of plasma protein abundance

Approved 27 Feb 23

Deep learning-enabled Oropharyngeal Squamous Cell Carcinoma HPV status determination from H&E stains

Approved 03 November 2022

Salivary proteomic biomarkers for head & neck cancer: a case-control study

Approved 09 September 2022

Effect of smoking and alcohol cessation on prognosis from head and neck cancer 

Approved 17 May 2022

Outcomes following definitive chemoradiotherapy for nasopharynx cancer

Approved 27 October 2021

Using Head and Neck 5000 data to analyse treatment outcome in laryngeal cancer: a preliminary study

Approved 29 September 2021

Using Artificial Intelligence for Salivary Gland Tumours Subtyping and Risk Stratification

Approved 19 August 2021

Pain, fatigue and functional outcomes

Approved 12 May 2021

AI in histology diagnosis of lymph node metastases

Approved 12 May 2021

Long term quality of life in people with head and neck cancer - the Big Data For Quality of Life (BD4QoL) historical study

Approved 14 April 2021

Mapping the genetic and epigenetic landscape for sinonasal carcinoma

Approved 17 March 2021

PET-CT guided, symptom-based, patient-initiated surveillance versus clinical follow-up in advanced head neck cancer (PetNeck2)

Approved 17 December 2020

Analysis of UK clinical practice and its impact on outcomes for non-surgically managed head and neck cancer patients

Approved 19 August 2020

HPV antibody patterns beyond HPV16 E6 seropositivity in head and neck cancer

Approved 19 August 2020

Epstein-Barr virus antibody pattern in head and neck cancer outside nasophayngeal carcinoma

Approved 05 Aug 2020

Validation of individualized prognostic calculator for patients with newly diagnosed head and neck cancer

Approved  13 May 2020

GREAT (GeRiatric Epidemiology and Treatment) for elderly Head and Neck Cancer patients in the UK

Approved 29 April 2020

Problems with nutritional intake on health-related quality of life and survival in survivors of head and neck cancer

Approved 29 April 2020

The role of somatic mutations in head and neck cancers outside of the oral cavity and oropharynx

Approved 21 August 2019

Translational studies of Head and Neck Cancer in South America and Europe (HEADSpAcE)

Approved 04 July 2019

Validating the PredicTR-OPC treatment response classifier for oropharyngeal cancer (PredicTR 2)

Approved 13 May 2019

To clarify the role of human papillomavirus in head and neck cancer by identifying HPV driven cancers

Approved 11 April 2018

Testing a longitudinal predictor-process-outcome model of clinical and well-being outcomes for patients with head and neck cancer

Approved 11 January 2018

Genome Wide Association Study of Head and Neck Cancer progression

Approved 22 November 2017

The role of germline and somatic DNA mutations in oral and oropharyngeal cancers (Voyager)

Approved 21 July 2017

The design and testing of path model to summarise the development of distress and fears of recurrence in patients with head & neck cancer one year following diagnosis

Approved 15 April 2016

Identifying epigenetic biomarkers in cancers of the head and neck

Approved 15 April 2016

The construction of a percentile calculator for identifying the rarity of fears of cancer (FCR) in head and neck cancer patients

Approved 15 April 2016